UniProt ID | BAZ2A_HUMAN | |
---|---|---|
UniProt AC | Q9UIF9 | |
Protein Name | Bromodomain adjacent to zinc finger domain protein 2A | |
Gene Name | BAZ2A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1905 | |
Subcellular Localization | Nucleus, nucleolus. Colocalizes with the basal RNA polymerase I transcription factor UBF in the nucleolus.. | |
Protein Description | Essential component of the NoRC (nucleolar remodeling complex) complex, a complex that mediates silencing of a fraction of rDNA by recruiting histone-modifying enzymes and DNA methyltransferases, leading to heterochromatin formation and transcriptional silencing. In the complex, it plays a central role by being recruited to rDNA and by targeting chromatin modifying enzymes such as HDAC1, leading to repress RNA polymerase I transcription. Recruited to rDNA via its interaction with TTF1 and its ability to recognize and bind histone H4 acetylated on 'Lys-16' (H4K16ac), leading to deacetylation of H4K5ac, H4K8ac, H4K12ac but not H4K16ac. Specifically binds pRNAs, 150-250 nucleotide RNAs that are complementary in sequence to the rDNA promoter; pRNA-binding is required for heterochromatin formation and rDNA silencing (By similarity).. | |
Protein Sequence | MEMEANDHFNFTGLPPAPAASGLKPSPSSGEGLYTNGSPMNFPQQGKSLNGDVNVNGLSTVSHTTTSGILNSAPHSSSTSHLHHPSVAYDCLWNYSQYPSANPGSNLKDPPLLSQFSGGQYPLNGILGGSRQPSSPSHNTNLRAGSQEFWANGTQSPMGLNFDSQELYDSFPDQNFEVMPNGPPSFFTSPQTSPMLGSSIQTFAPSQEVGSGIHPDEAAEKEMTSVVAENGTGLVGSLELEEEQPELKMCGYNGSVPSVESLHQEVSVLVPDPTVSCLDDPSHLPDQLEDTPILSEDSLEPFNSLAPEPVSGGLYGIDDTELMGAEDKLPLEDSPVISALDCPSLNNATAFSLLADDSQTSTSIFASPTSPPVLGESVLQDNSFDLNNGSDAEQEEMETQSSDFPPSLTQPAPDQSSTIQLHPATSPAVSPTTSPAVSLVVSPAASPEISPEVCPAASTVVSPAVFSVVSPASSAVLPAVSLEVPLTASVTSPKASPVTSPAAAFPTASPANKDVSSFLETTADVEEITGEGLTASGSGDVMRRRIATPEEVRLPLQHGWRREVRIKKGSHRWQGETWYYGPCGKRMKQFPEVIKYLSRNVVHSVRREHFSFSPRMPVGDFFEERDTPEGLQWVQLSAEEIPSRIQAITGKRGRPRNTEKAKTKEVPKVKRGRGRPPKVKITELLNKTDNRPLKKLEAQETLNEEDKAKIAKSKKKMRQKVQRGECQTTIQGQARNKRKQETKSLKQKEAKKKSKAEKEKGKTKQEKLKEKVKREKKEKVKMKEKEEVTKAKPACKADKTLATQRRLEERQRQQMILEEMKKPTEDMCLTDHQPLPDFSRVPGLTLPSGAFSDCLTIVEFLHSFGKVLGFDPAKDVPSLGVLQEGLLCQGDSLGEVQDLLVRLLKAALHDPGFPSYCQSLKILGEKVSEIPLTRDNVSEILRCFLMAYGVEPALCDRLRTQPFQAQPPQQKAAVLAFLVHELNGSTLIINEIDKTLESMSSYRKNKWIVEGRLRRLKTVLAKRTGRSEVEMEGPEECLGRRRSSRIMEETSGMEEEEEEESIAAVPGRRGRRDGEVDATASSIPELERQIEKLSKRQLFFRKKLLHSSQMLRAVSLGQDRYRRRYWVLPYLAGIFVEGTEGNLVPEEVIKKETDSLKVAAHASLNPALFSMKMELAGSNTTASSPARARGRPRKTKPGSMQPRHLKSPVRGQDSEQPQAQLQPEAQLHAPAQPQPQLQLQLQSHKGFLEQEGSPLSLGQSQHDLSQSAFLSWLSQTQSHSSLLSSSVLTPDSSPGKLDPAPSQPPEEPEPDEAESSPDPQALWFNISAQMPCNAAPTPPPAVSEDQPTPSPQQLASSKPMNRPSAANPCSPVQFSSTPLAGLAPKRRAGDPGEMPQSPTGLGQPKRRGRPPSKFFKQMEQRYLTQLTAQPVPPEMCSGWWWIRDPEMLDAMLKALHPRGIREKALHKHLNKHRDFLQEVCLRPSADPIFEPRQLPAFQEGIMSWSPKEKTYETDLAVLQWVEELEQRVIMSDLQIRGWTCPSPDSTREDLAYCEHLSDSQEDITWRGRGREGLAPQRKTTNPLDLAVMRLAALEQNVERRYLREPLWPTHEVVLEKALLSTPNGAPEGTTTEISYEITPRIRVWRQTLERCRSAAQVCLCLGQLERSIAWEKSVNKVTCLVCRKGDNDEFLLLCDGCDRGCHIYCHRPKMEAVPEGDWFCTVCLAQQVEGEFTQKPGFPKRGQKRKSGYSLNFSEGDGRRRRVLLRGRESPAAGPRYSEEGLSPSKRRRLSMRNHHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRERLLRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFYQGKQANL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
21 | Phosphorylation | LPPAPAASGLKPSPS CCCCCCCCCCCCCCC | 46.92 | 26074081 | |
26 | Phosphorylation | AASGLKPSPSSGEGL CCCCCCCCCCCCCCC | 35.51 | 26074081 | |
28 | Phosphorylation | SGLKPSPSSGEGLYT CCCCCCCCCCCCCCC | 56.14 | 26074081 | |
29 | Phosphorylation | GLKPSPSSGEGLYTN CCCCCCCCCCCCCCC | 44.22 | 26074081 | |
34 | Phosphorylation | PSSGEGLYTNGSPMN CCCCCCCCCCCCCCC | 14.71 | 26074081 | |
35 | Phosphorylation | SSGEGLYTNGSPMNF CCCCCCCCCCCCCCC | 37.84 | 25627689 | |
38 | Phosphorylation | EGLYTNGSPMNFPQQ CCCCCCCCCCCCCCC | 24.05 | 25159151 | |
67 | Phosphorylation | TVSHTTTSGILNSAP ECEEECCCCHHHCCC | 23.03 | - | |
114 | Phosphorylation | LKDPPLLSQFSGGQY CCCCCHHHHCCCCCC | 36.54 | 23090842 | |
117 | Phosphorylation | PPLLSQFSGGQYPLN CCHHHHCCCCCCCCC | 34.08 | 23090842 | |
121 | Phosphorylation | SQFSGGQYPLNGILG HHCCCCCCCCCCCCC | 16.98 | 23090842 | |
130 | Phosphorylation | LNGILGGSRQPSSPS CCCCCCCCCCCCCCC | 26.41 | 23090842 | |
134 | Phosphorylation | LGGSRQPSSPSHNTN CCCCCCCCCCCCCCC | 46.68 | 30266825 | |
135 | Phosphorylation | GGSRQPSSPSHNTNL CCCCCCCCCCCCCCC | 36.79 | 23401153 | |
137 | Phosphorylation | SRQPSSPSHNTNLRA CCCCCCCCCCCCCCC | 31.17 | 30266825 | |
137 (in isoform 2) | Phosphorylation | - | 31.17 | 21406692 | |
138 (in isoform 2) | Phosphorylation | - | 48.82 | 21406692 | |
140 | Phosphorylation | PSSPSHNTNLRAGSQ CCCCCCCCCCCCCCC | 30.15 | 23403867 | |
154 | Phosphorylation | QEFWANGTQSPMGLN CCHHHCCCCCCCCCC | 26.19 | 26074081 | |
156 | Phosphorylation | FWANGTQSPMGLNFD HHHCCCCCCCCCCCC | 19.38 | 26074081 | |
311 | Phosphorylation | SLAPEPVSGGLYGID HCCCCCCCCCCCCCC | 37.55 | 26074081 | |
315 | Phosphorylation | EPVSGGLYGIDDTEL CCCCCCCCCCCHHHC | 18.47 | 26074081 | |
352 | Phosphorylation | LNNATAFSLLADDSQ CCCHHHHHHHCCCCC | 21.73 | 26074081 | |
358 | Phosphorylation | FSLLADDSQTSTSIF HHHHCCCCCCCCCEE | 35.59 | 26074081 | |
360 | Phosphorylation | LLADDSQTSTSIFAS HHCCCCCCCCCEECC | 37.61 | 26074081 | |
361 | Phosphorylation | LADDSQTSTSIFASP HCCCCCCCCCEECCC | 16.72 | 26074081 | |
367 | Phosphorylation | TSTSIFASPTSPPVL CCCCEECCCCCCCCC | 20.26 | 26074081 | |
369 | Phosphorylation | TSIFASPTSPPVLGE CCEECCCCCCCCCCC | 51.90 | 26074081 | |
370 | Phosphorylation | SIFASPTSPPVLGES CEECCCCCCCCCCCC | 30.50 | 26074081 | |
469 | Phosphorylation | SPAVFSVVSPASSAV CCHHHCCCCCCCCCC | 5.70 | 15302935 | |
473 (in isoform 2) | Phosphorylation | - | 23.39 | 21406692 | |
480 (in isoform 2) | Phosphorylation | - | 6.74 | 21406692 | |
482 (in isoform 2) | Phosphorylation | - | 6.55 | 21406692 | |
487 | Phosphorylation | VSLEVPLTASVTSPK EEEEEEEEEEECCCC | 15.71 | 26074081 | |
489 | Phosphorylation | LEVPLTASVTSPKAS EEEEEEEEECCCCCC | 22.23 | 26074081 | |
491 | Phosphorylation | VPLTASVTSPKASPV EEEEEEECCCCCCCC | 36.50 | 26074081 | |
492 | Phosphorylation | PLTASVTSPKASPVT EEEEEECCCCCCCCC | 23.42 | 26074081 | |
494 | Phosphorylation | TASVTSPKASPVTSP EEEECCCCCCCCCCC | 62.35 | 18669648 | |
496 | Phosphorylation | SVTSPKASPVTSPAA EECCCCCCCCCCCCH | 26.48 | 30266825 | |
499 | Phosphorylation | SPKASPVTSPAAAFP CCCCCCCCCCCHHCC | 32.17 | 30266825 | |
500 | O-linked_Glycosylation | PKASPVTSPAAAFPT CCCCCCCCCCHHCCC | 16.87 | 30379171 | |
500 | Phosphorylation | PKASPVTSPAAAFPT CCCCCCCCCCHHCCC | 16.87 | 30266825 | |
507 | Phosphorylation | SPAAAFPTASPANKD CCCHHCCCCCCCCCC | 33.06 | 30266825 | |
509 | Phosphorylation | AAAFPTASPANKDVS CHHCCCCCCCCCCHH | 27.33 | 30266825 | |
513 | Acetylation | PTASPANKDVSSFLE CCCCCCCCCHHHHHH | 62.71 | 26051181 | |
516 | Phosphorylation | SPANKDVSSFLETTA CCCCCCHHHHHHHCC | 26.04 | 26074081 | |
517 | Phosphorylation | PANKDVSSFLETTAD CCCCCHHHHHHHCCC | 33.43 | 26074081 | |
521 | Phosphorylation | DVSSFLETTADVEEI CHHHHHHHCCCHHHH | 29.45 | 18669648 | |
548 | O-linked_Glycosylation | VMRRRIATPEEVRLP HHHCCCCCHHHCCCC | 28.94 | 30379171 | |
548 | Phosphorylation | VMRRRIATPEEVRLP HHHCCCCCHHHCCCC | 28.94 | 30266825 | |
568 | Ubiquitination | RREVRIKKGSHRWQG EEEEEEECCCCCCCC | 64.37 | - | |
585 | Acetylation | WYYGPCGKRMKQFPE EEECCCCHHHHHHHH | 56.91 | 26051181 | |
585 | Methylation | WYYGPCGKRMKQFPE EEECCCCHHHHHHHH | 56.91 | - | |
595 | Ubiquitination | KQFPEVIKYLSRNVV HHHHHHHHHHHHHHH | 45.36 | 21906983 | |
604 | Phosphorylation | LSRNVVHSVRREHFS HHHHHHHHHHHHHCC | 13.00 | - | |
611 | Phosphorylation | SVRREHFSFSPRMPV HHHHHHCCCCCCCCC | 27.07 | 22617229 | |
613 | Phosphorylation | RREHFSFSPRMPVGD HHHHCCCCCCCCCHH | 15.48 | 26055452 | |
649 | Phosphorylation | PSRIQAITGKRGRPR CHHHHHHHCCCCCCC | 39.40 | - | |
651 | Acetylation | RIQAITGKRGRPRNT HHHHHHCCCCCCCCC | 42.92 | 25953088 | |
680 | Acetylation | RGRPPKVKITELLNK CCCCCCCCHHHHCCC | 50.46 | 19578370 | |
687 | Acetylation | KITELLNKTDNRPLK CHHHHCCCCCCCCCH | 58.17 | 23236377 | |
688 | Phosphorylation | ITELLNKTDNRPLKK HHHHCCCCCCCCCHH | 37.12 | 28555341 | |
695 | Sumoylation | TDNRPLKKLEAQETL CCCCCCHHHHHHHHC | 60.28 | - | |
695 | Sumoylation | TDNRPLKKLEAQETL CCCCCCHHHHHHHHC | 60.28 | - | |
701 | Phosphorylation | KKLEAQETLNEEDKA HHHHHHHHCCHHHHH | 23.85 | 24173317 | |
707 | Acetylation | ETLNEEDKAKIAKSK HHCCHHHHHHHHHHH | 55.66 | 23236377 | |
737 | Acetylation | IQGQARNKRKQETKS HHHHHHHHHHHHHHH | 56.25 | 7367297 | |
739 | Acetylation | GQARNKRKQETKSLK HHHHHHHHHHHHHHH | 54.84 | 7367309 | |
742 | O-linked_Glycosylation | RNKRKQETKSLKQKE HHHHHHHHHHHHHHH | 24.36 | 30379171 | |
767 | Acetylation | KGKTKQEKLKEKVKR HCCHHHHHHHHHHHH | 63.47 | 7258197 | |
799 | Acetylation | KPACKADKTLATQRR CHHCHHCHHHHHHHH | 50.74 | 25953088 | |
800 | Phosphorylation | PACKADKTLATQRRL HHCHHCHHHHHHHHH | 23.36 | 29759185 | |
803 | Phosphorylation | KADKTLATQRRLEER HHCHHHHHHHHHHHH | 26.22 | 29759185 | |
866 | Sumoylation | EFLHSFGKVLGFDPA HHHHHHHHHHCCCCC | 32.07 | 28112733 | |
921 | Acetylation | PSYCQSLKILGEKVS HHHHHHHHHHCCCCC | 40.92 | 26051181 | |
928 | Phosphorylation | KILGEKVSEIPLTRD HHHCCCCCCCCCCCC | 40.66 | 21406692 | |
995 | Phosphorylation | IINEIDKTLESMSSY EEHHHHHHHHHHHHH | 31.82 | - | |
1006 | Acetylation | MSSYRKNKWIVEGRL HHHHHCCCHHHHHHH | 41.13 | 25953088 | |
1023 (in isoform 2) | Phosphorylation | - | 36.48 | 21406692 | |
1024 | Phosphorylation | KTVLAKRTGRSEVEM HHHHHHHHCCCCCEE | 35.92 | 21712546 | |
1024 (in isoform 2) | Phosphorylation | - | 35.92 | 21406692 | |
1027 | Phosphorylation | LAKRTGRSEVEMEGP HHHHHCCCCCEECCH | 47.54 | 21712546 | |
1043 | Phosphorylation | ECLGRRRSSRIMEET HHHCCHHHHHHHHHC | 23.35 | - | |
1044 | Phosphorylation | CLGRRRSSRIMEETS HHCCHHHHHHHHHCC | 24.82 | - | |
1050 | Phosphorylation | SSRIMEETSGMEEEE HHHHHHHCCCCCHHH | 19.78 | 30266825 | |
1051 | Phosphorylation | SRIMEETSGMEEEEE HHHHHHCCCCCHHHH | 39.15 | 23401153 | |
1061 | Phosphorylation | EEEEEEESIAAVPGR CHHHHHHHHCCCCCC | 22.32 | 30278072 | |
1125 | Phosphorylation | QDRYRRRYWVLPYLA CHHHHHHHCHHHHHE | 9.69 | 21118733 | |
1130 | Phosphorylation | RRYWVLPYLAGIFVE HHHCHHHHHEEEEEE | 12.67 | 21118733 | |
1150 | Sumoylation | LVPEEVIKKETDSLK CCCHHHHHHCCCCHH | 50.13 | 28112733 | |
1163 | Phosphorylation | LKVAAHASLNPALFS HHHHHHHHCCHHHHH | 20.86 | 28111955 | |
1170 | Phosphorylation | SLNPALFSMKMELAG HCCHHHHHHHEECCC | 20.53 | 24719451 | |
1172 | Sumoylation | NPALFSMKMELAGSN CHHHHHHHEECCCCC | 28.20 | - | |
1172 | Sumoylation | NPALFSMKMELAGSN CHHHHHHHEECCCCC | 28.20 | 28112733 | |
1178 | Phosphorylation | MKMELAGSNTTASSP HHEECCCCCCCCCCC | 25.95 | 23403867 | |
1180 | Phosphorylation | MELAGSNTTASSPAR EECCCCCCCCCCCHH | 25.99 | 23403867 | |
1180 (in isoform 2) | Phosphorylation | - | 25.99 | 21406692 | |
1181 | Phosphorylation | ELAGSNTTASSPARA ECCCCCCCCCCCHHH | 28.88 | 23403867 | |
1183 | Phosphorylation | AGSNTTASSPARARG CCCCCCCCCCHHHCC | 34.46 | 30266825 | |
1184 | Phosphorylation | GSNTTASSPARARGR CCCCCCCCCHHHCCC | 21.81 | 30266825 | |
1195 | Phosphorylation | ARGRPRKTKPGSMQP HCCCCCCCCCCCCCC | 43.69 | 23828894 | |
1207 | Phosphorylation | MQPRHLKSPVRGQDS CCCCCCCCCCCCCCC | 34.68 | 30266825 | |
1210 | Methylation | RHLKSPVRGQDSEQP CCCCCCCCCCCCCCC | 40.20 | - | |
1214 | Phosphorylation | SPVRGQDSEQPQAQL CCCCCCCCCCCCHHC | 30.18 | 30576142 | |
1243 | Phosphorylation | QLQLQLQSHKGFLEQ CHHHHHHHHCCHHHC | 35.44 | 24144214 | |
1343 | Phosphorylation | PTPPPAVSEDQPTPS CCCCCCCCCCCCCCC | 37.25 | 18669648 | |
1350 | Phosphorylation | SEDQPTPSPQQLASS CCCCCCCCHHHHHCC | 37.51 | 26657352 | |
1364 | Phosphorylation | SKPMNRPSAANPCSP CCCCCCCCCCCCCCC | 36.45 | 30576142 | |
1370 | Phosphorylation | PSAANPCSPVQFSST CCCCCCCCCCCCCCC | 29.39 | 25159151 | |
1370 (in isoform 2) | Phosphorylation | - | 29.39 | 21406692 | |
1372 (in isoform 2) | Phosphorylation | - | 5.29 | 21406692 | |
1375 | Phosphorylation | PCSPVQFSSTPLAGL CCCCCCCCCCCCCCC | 19.06 | 22199227 | |
1376 | Phosphorylation | CSPVQFSSTPLAGLA CCCCCCCCCCCCCCC | 35.02 | 22199227 | |
1377 | Phosphorylation | SPVQFSSTPLAGLAP CCCCCCCCCCCCCCC | 22.56 | 30576142 | |
1397 | Phosphorylation | DPGEMPQSPTGLGQP CCCCCCCCCCCCCCC | 20.68 | 29255136 | |
1399 | Phosphorylation | GEMPQSPTGLGQPKR CCCCCCCCCCCCCCC | 50.73 | 29255136 | |
1467 | Ubiquitination | IREKALHKHLNKHRD HHHHHHHHHHHHCHH | 51.11 | - | |
1503 | Phosphorylation | AFQEGIMSWSPKEKT HHHHCCCCCCCCCCC | 23.60 | 28348404 | |
1505 | Phosphorylation | QEGIMSWSPKEKTYE HHCCCCCCCCCCCHH | 20.84 | 27050516 | |
1531 | Phosphorylation | LEQRVIMSDLQIRGW HHHHHHHCCCEECCE | 24.84 | 20068231 | |
1532 | Phosphorylation | EQRVIMSDLQIRGWT HHHHHHCCCEECCEE | 25.80 | 17525332 | |
1539 | Phosphorylation | DLQIRGWTCPSPDST CCEECCEECCCCCCC | 19.84 | 30266825 | |
1542 | Phosphorylation | IRGWTCPSPDSTRED ECCEECCCCCCCHHH | 43.41 | 30266825 | |
1545 | Phosphorylation | WTCPSPDSTREDLAY EECCCCCCCHHHHHH | 32.52 | 23663014 | |
1546 | Phosphorylation | TCPSPDSTREDLAYC ECCCCCCCHHHHHHC | 45.52 | 23663014 | |
1552 | Phosphorylation | STREDLAYCEHLSDS CCHHHHHHCCCCCCC | 12.98 | 30266825 | |
1557 | Phosphorylation | LAYCEHLSDSQEDIT HHHCCCCCCCCCCCC | 36.80 | 30266825 | |
1559 | Phosphorylation | YCEHLSDSQEDITWR HCCCCCCCCCCCCCC | 31.90 | 17525332 | |
1564 | Phosphorylation | SDSQEDITWRGRGRE CCCCCCCCCCCCCCC | 22.79 | 30108239 | |
1579 | Phosphorylation | GLAPQRKTTNPLDLA CCCCCCCCCCHHHHH | 33.71 | 20068231 | |
1580 | Phosphorylation | LAPQRKTTNPLDLAV CCCCCCCCCHHHHHH | 37.56 | 20068231 | |
1620 | Phosphorylation | VLEKALLSTPNGAPE HHHHHHHCCCCCCCC | 42.54 | 27050516 | |
1621 | Phosphorylation | LEKALLSTPNGAPEG HHHHHHCCCCCCCCC | 22.27 | 22199227 | |
1629 | Phosphorylation | PNGAPEGTTTEISYE CCCCCCCCCEEEEEE | 28.96 | 22199227 | |
1630 | Phosphorylation | NGAPEGTTTEISYEI CCCCCCCCEEEEEEE | 33.03 | 22199227 | |
1631 | Phosphorylation | GAPEGTTTEISYEIT CCCCCCCEEEEEEEC | 31.03 | 26714015 | |
1634 | Phosphorylation | EGTTTEISYEITPRI CCCCEEEEEEECHHH | 15.52 | 20068231 | |
1635 | Phosphorylation | GTTTEISYEITPRIR CCCEEEEEEECHHHH | 19.60 | 20068231 | |
1672 | Ubiquitination | ERSIAWEKSVNKVTC HHHHHHHHCCCEEEE | 49.34 | - | |
1672 (in isoform 3) | Ubiquitination | - | 49.34 | 21890473 | |
1676 | Sumoylation | AWEKSVNKVTCLVCR HHHHCCCEEEEEEEE | 36.44 | 28112733 | |
1676 | Ubiquitination | AWEKSVNKVTCLVCR HHHHCCCEEEEEEEE | 36.44 | 21890473 | |
1676 (in isoform 1) | Ubiquitination | - | 36.44 | 21890473 | |
1709 | Sumoylation | HIYCHRPKMEAVPEG EEEECCCCCCCCCCC | 49.70 | 28112733 | |
1746 | Acetylation | PKRGQKRKSGYSLNF CCCCCCCCCCEECCC | 56.09 | 20167786 | |
1747 | Phosphorylation | KRGQKRKSGYSLNFS CCCCCCCCCEECCCC | 47.17 | 25159151 | |
1749 | Phosphorylation | GQKRKSGYSLNFSEG CCCCCCCEECCCCCC | 19.64 | 22199227 | |
1750 | Phosphorylation | QKRKSGYSLNFSEGD CCCCCCEECCCCCCC | 21.99 | 25159151 | |
1754 | Phosphorylation | SGYSLNFSEGDGRRR CCEECCCCCCCCCCE | 39.33 | 23403867 | |
1756 (in isoform 2) | Phosphorylation | - | 41.28 | 21406692 | |
1758 (in isoform 2) | Phosphorylation | - | 35.53 | 21406692 | |
1768 | Methylation | RRVLLRGRESPAAGP EEEEECCCCCCCCCC | 34.48 | - | |
1770 | Phosphorylation | VLLRGRESPAAGPRY EEECCCCCCCCCCCC | 20.62 | 30266825 | |
1776 | Methylation | ESPAAGPRYSEEGLS CCCCCCCCCCCCCCC | 46.84 | - | |
1777 | Phosphorylation | SPAAGPRYSEEGLSP CCCCCCCCCCCCCCH | 24.46 | 23927012 | |
1778 | Phosphorylation | PAAGPRYSEEGLSPS CCCCCCCCCCCCCHH | 30.37 | 23927012 | |
1783 | Phosphorylation | RYSEEGLSPSKRRRL CCCCCCCCHHHHHHH | 37.67 | 29255136 | |
1785 | Phosphorylation | SEEGLSPSKRRRLSM CCCCCCHHHHHHHHC | 35.10 | 30266825 | |
1786 | Acetylation | EEGLSPSKRRRLSMR CCCCCHHHHHHHHCC | 53.99 | 25953088 | |
1786 | Ubiquitination | EEGLSPSKRRRLSMR CCCCCHHHHHHHHCC | 53.99 | - | |
1787 | Methylation | EGLSPSKRRRLSMRN CCCCHHHHHHHHCCH | 33.03 | - | |
1841 | Phosphorylation | IKNPMDFSTMRERLL HCCCCCHHHHHHHHH | 19.61 | 23403867 | |
1842 | Phosphorylation | KNPMDFSTMRERLLR CCCCCHHHHHHHHHC | 21.90 | 23403867 | |
1901 | Ubiquitination | WEEFYQGKQANL--- HHHHHCHHHCCC--- | 30.61 | 21906983 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
509 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
680 | K | Acetylation |
| 19578370 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BAZ2A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SMCA5_HUMAN | SMARCA5 | physical | 11532953 | |
KAT8_HUMAN | KAT8 | physical | 19578370 | |
SMCA5_HUMAN | SMARCA5 | physical | 19578370 | |
HDAC1_HUMAN | HDAC1 | physical | 16085498 | |
DNMT1_HUMAN | DNMT1 | physical | 16085498 | |
DNM3B_HUMAN | DNMT3B | physical | 16085498 | |
SMCA5_HUMAN | SMARCA5 | physical | 16085498 | |
BEND3_HUMAN | BEND3 | physical | 26100909 | |
UBP21_HUMAN | USP21 | physical | 26100909 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Reversible acetylation of the chromatin remodelling complex NoRC isrequired for non-coding RNA-dependent silencing."; Zhou Y., Schmitz K.M., Mayer C., Yuan X., Akhtar A., Grummt I.; Nat. Cell Biol. 11:1010-1016(2009). Cited for: ACETYLATION AT LYS-680. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1050; SER-1051; SER-1397AND SER-1783, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-509; SER-1184; SER-1397AND SER-1783, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-548; SER-1747; SER-1770;SER-1778 AND SER-1783, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1397, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-548 AND SER-1747, ANDMASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1559, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1397, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-496, AND MASSSPECTROMETRY. |